Senior insider sale
ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$984.0K
39.27K shares
What this filing means
CURRAN TERRIE plans to sell 39.27K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $984.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/27/2026ACC: 0001628280-26-059254
Director
Since Nov 2020
39.27K
Shares to sell
$984.0K
Approx. market value
38.20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
6/14/2024
27.05KStock Option Exercise
Cash
5/31/2023
11.15KTotal acquired38.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/14/2024 | Stock Option Exercise Cash | 27.05K | — |
5/31/2023 | Stock Option Exercise Cash | 11.15K | — |
| Total | 38.20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.07K
Market value
$27.9K
8/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
38.20K
Market value
$956.1K
8/27/2026
Total
Units
39.27K
Value
$984.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/20/2026 | 1.07K | $27.9K | — | Completed |
| Planned — Approximate Date | ||||
8/27/2026 | 38.20K | $956.1K | NASDAQ | Planned |
| Total | 39.27K | $984.0K | ||